Kiniksa Pharmaceuticals International Plc (KNSA)
46.16
+0.14
(+0.30%)
USD |
NASDAQ |
Mar 06, 16:00
46.24
+0.08
(+0.17%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International Cash from Investing (TTM) : -188.99M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Marker Therapeutics, Inc. | 0.00 |
| NovoCure Ltd. | 437.28M |
| LivaNova Plc | -72.91M |
| Alterola Biotech, Inc. | -- |
| Akanda Corp. | -1.12M |